Basson R, Leiblum S, Brotto L, et al. Definitions of women's sexual dysfunctions reconsidered: advocating expansion and revision. J Psychosom Obstet Gynaecol. 2003;24:221-229.
Basson R, Schultz WW. Sexual sequelae of general medical disorders. Lancet. 2007;369:409-424.
Goldhammer DL, McCabe MP. A qualitative exploration of the meaning and experience of sexual desire among partnered women. Can J Hum Sex. 2011;20:19-34.
Wierman ME, Nappi RE, Avis N, et al. Endocrine aspects of women's sexual function. J Sex Med. 2010;7:561-585.
Leddy L, Yang C, Stuckey B, et al. Influence of PDE5 inhibitor on genital engorgement in women with female sexual arousal disorder. J Sex Med 2011;8(suppl 2):63.
Bradford A. Listening to placebo in clinical trials for female sexual dysfunction. J Sex Med. 2013;10:451-459.
1. Basson R, Leiblum S, Brotto L, et al. Definitions of women's sexual dysfunctions reconsidered: advocating expansion and revision. J Psychosom Obstet Gynaecol. 2003;24:221-229.
2. Maserejian NN, Shifren JL, Parish J, et al. The presentation of hypoactive sexual desire disorder in premenopausal women. J Sex Med. 2010;7:3439-3448.
3. Bancroft J, Loftus J, Long JS. Distress about sex: a national survey of women in heterosexual relationships. Arch Sex Behav. 2003;32:193-208.
4. Hartmann U, Philippsohn S, Heiser K, et al. Low desire in midlife and older women: personality factors, psychosocial development, present sexuality. Menopause. 2004;11:726-740.
5. Avis NE, Stellato R, Crawford S, et al. Is there an association between menopause status and sexual functioning? Menopause. 2000;7:297-309.
6. Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during mid-life due to aging or menopause? Fertil Steril. 2001;76:456-460.
7. Santoro N, Torrens J, Crawford S, et al. Correlates of circulating androgens in midlife women: the study of women's health across the nation. J Clin Endocrinol Metab. 2005;90:4836-4845.
8. Davis SR, Davison SL, Donath S, et al. Circulating androgen levels and self-reported sexual function in women. JAMA. 2005;294:91-96.
9. Basson R, Brotto LA, Petkau AJ, et al. Role of androgens in women’s sexual dysfunction. Menopause. 2010;17:962-971.
10. Erekson EA, Martin DK, Zhu K, et al. Sexual function in older women after oophorectomy. Obstet Gynecol. 2012;120:833-842.
11. van Anders SM. Testosterone and sexual desire in healthy women and men. Arch Sex Behav. 2012;41:1471-1484.
12. Facelle TM, Sadeghi-Nejad H, Goldmeier D. Persistent genital arousal disorder: characterization, etiology, and management. J Sex Med. 2013;10:439-450.
13. Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Arch Sex Behav. 2010;39:221-239.
14. Graham CA. The DSM diagnostic criteria for female sexual arousal disorder. Arch Sex Behav. 2010;39:240-255.
15. Mitchell KR, Mercer CH, Ploubidis GB, et al. Sexual function in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Lancet. 2013;382:1817-1829.
16. Leiblum SR, Koochaki PE, Rodenberg CA, et al. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause. 2006;13:46-56.
17. Dennerstein L, Koochaki P, Barton I, et al. Hypoactive sexual desire disorder in menopausal women: a survey of western European women. J Sex Med. 2006;3:212-222.
18. Mitchell KR, Mercer CH, Wellings K, et al. Prevalence of low sexual desire among women in Britain: associated factors. J Sex Med. 2009;6:2434-2444.
19. West SL, D'Aloisio AA, Agans RP, et al. The prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med. 2008;168:1441-1449.
20. Addis IB, Van Den Eeden SK, Wassel-Fyr CL, et al. Sexual activity and function in middle-aged and older women. Obstet Gynecol. 2006;107:755-764.
21. Cain VS, Johannes CB, Avis NE, et al. Sexual functioning and practices in a multi-ethnic study of midlife women: baseline results from SWAN. J Sex Res. 2003;40:266-276.
22. Laumann EO, Nicolosi A, Glasser DB, et al. Sexual problems among women and men, aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviours. Int J Impot Res. 2005;17:39-57.
23. Basson R. Sexual desire and arousal disorders in women. N Engl J Med. 2006;354:1497-1506.
24. McCabe M, Althof SE, Assalian P, et al. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med. 2010;7:327-336.
25. Scharff DE. Life processes that restructure relationships. In: Levine SB, Risen CB, Althof SE, eds. Handbook of clinical sexuality. New York, NY: Brunner-Routledge; 2003:37-55.
26. Staples J, Rellini AH, Roberts SP. Avoiding experiences: sexual dysfunction in women with a history of sexual abuse in childhood and adolescence. Arch Sex Behav. 2012;41:341-350.
27. Cayan S, Bozlu M, Canpolat B, et al. The assessment of sexual functions in women with male partners complaining of erectile dysfunction: does treatment of male sexual dysfunction improve female partner's sexual functions? J Sex Marital Ther. 2004;30:333-341.
28. Basson R, Schultz WW. Sexual sequelae of general medical disorders. Lancet. 2007;369:409-424.
29. Basson R, Bronner G. Management and rehabilitation of neurologic patients with sexual dysfunction. In: Vodusek DB, Boller F, eds. Handbook of clinical neurology. Vol. 130. Waltham, MA: Elsevier; 2015:415-434.
30. Clayton AH, Pradko JF, Croft HA, et al. Prevalence of sexual dysfunction among newer anti-depressants. J Clin Psychiatry. 2002;63:357-366.
31. Battaglia C, Battaglia B, Mancini F, et al. Sexual behavior and oral contraception: a pilot study. J Sex Med. 2012;9:550-557.
32. Teplin V, Vittinghoff E, Lin F, et al. Oophorectomy in premenopausal women: health-related quality of life and sexual functioning. Obstet Gynecol. 2007;109:347-354.
33. Heiman JR. Orgasmic disorders in women. In: Leiblum SR, ed. Principles and practice of sex therapy. 4th ed. New York, NY: Guilford Press; 2007:66-68.
34. Leiblum S, Seehuus M, Brown C. Persistent genital arousal: disordered or normative aspect of female sexual response? J Sex Med. 2007;4:680-689.
35. Pereira VM, Silva AC, Nardi AE. Persistent genital arousal disorder: A literature review. Jornal Brasileiro de Psiquiatria [in Portuguese]. 2010;59:223-232.
36. Waldinger MD, Schweitzer DH. Persistent genital arousal disorder in 18 Dutch women: part II. A syndrome clustered with restless legs and overactive bladder. J Sex Med. 2009;6:482-497.
37. Waldinger MD, de Lint GJ, Venema PL, et al. Successful transcutaneous electrical nerve stimulation in two women with restless genital syndrome: the role of adelta- and C-nerve fibers. J Sex Med. 2010;7:1190-1199.
38. Meston CM, Buss DM. Why humans have sex. Arch Sex Behav. 2007;36:477-507.
39. Goldhammer DL, McCabe MP. A qualitative exploration of the meaning and experience of sexual desire among partnered women. Can J Hum Sex. 2011;20:19-34.
40. Chivers ML, Bailey JM. A sex difference in features that elicit genital response. Biol Psychol. 2005;70:115-120.
41. Chivers ML, Seto MC, Lalumière ML, et al. Agreement of self-reported and genital measures of sexual arousal in men and women: a meta-analysis. Arch Sex Behav. 2010;39:5-56.
42. Heiman JR, Rupp H, Janssen E, et al. Sexual desire, sexual arousal and hormonal differences in premenopausal US and Dutch women with and without low sexual desire. Horm Behav. 2011;59:772-779.
43. Labrie F, Archer D, Bouchard C, et al. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause. 2009;16:923-931.
44. Wåhlin-Jacobsen S, Pedersen AT, Kristensen E, et al. Is there a correlation between androgens and sexual desire in women? J Sex Med. 2015;12:358-373.
45. Kokcu A, Kurtoglu E, Bildircin D,et al. Does surgical menopause affect sexual performance differently from natural menopause? J Sex Med. 2015;12:1407-1414.
46. Randolph JF Jr, Zheng H, Avis NE, et al. Masturbation frequency and sexual function domains are associated with serum reproductive hormone levels across the menopausal transition. J Clin Endocrinol Metab. 2015;100:258-266.
47. Clayton A, Kornstein S, Prakash A, et al. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med. 2007;4:917-929.
48. Montejo AL, Perahia DG, Spann ME, et al. Sexual function during long-term duloxetine treatment in patients with recurrent major depressive disorder. J Sex Med. 2011;8:773-782.
49. Cyranowski JM, Bromberge J, Youk A, et al. Lifetime depression history and sexual function in women at midlife. Arch Sex Behav. 2004;33:539-548.
50. Bhasin S, Enzlin P, Coviello A, et al. Sexual dysfunction in men and women with endocrine disorders. Lancet. 2007;369:597-611.
51. Bull SA, Hu XH, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA. 2002;288:1403-1409.
52. Dunn KM, Croft PR, Hackett GI. Association of sexual problems with social, psychological, and physical problems in men and women: a cross-sectional population survey. J Epidemiol Community Health. 1999;53:144-148.
53. Barlow DH. Causes of sexual dysfunction: the role of anxiety and cognitive interference. J Consult Clin Psychol. 1986;54:140-148.
54. Krychman M, Millheiser LS. Sexual health issues in women with cancer. J Sex Med. 2013;10(suppl 1):5-15.
55. Ganz PA, Desmond KA, Belin TR, et al. Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol. 1999;17:2371-2380.
56. Andersen BL, Woods XA, Copeland LJ. Sexual self-schema and sexual morbidity among gynecologic cancer survivors. J Consult Clin Psychol. 1997;65:221-229.
57. Sadovsky R, Basson R, Krychman M, et al. Cancer and sexual problems. J Sex Med. 2010;7:349-373.
58. Melisko ME, Goldman M, Rugo HS. Amelioration of sexual adverse effects in the early breast cancer patient. J Cancer Surviv. 2010;4:247-255.
59. Taylor S, Harley C, Ziegler L, et al. Interventions for sexual problems following treatment for breast cancer: a systematic review. Breast Cancer Res Treat. 2011;130:711-724.
60. Baumgart J, Nilsson K, Evers AS, et al. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause. 2013;20:162-168.
61. Alder J, Zanetti R, Wight E, et al. Sexual dysfunction after premenopausal stage I and II breast cancer: do androgens play a role? J Sex Med. 2008;5:1898-1906.
62. Carter J, Stabile C, Gunn A, et al. The physical consequences of gynecologic cancer surgery and their impact on sexual, emotional, and quality of life issues. J Sex Med. 2013;10(suppl 1):21-34.
63. Abbott-Anderson K, Kwekkeboom KL. A systematic review of sexual concerns reported by gynecological cancer survivors. Gynecol Oncol. 2012;124:477-489.
64. Incrocci L, Jensen PT. Pelvic radiotherapy and sexual function in men and women. J Sex Med. 2013;10(suppl 1):53-64.
65. Rees P, Fowler CJ, Maas CP. Sexual function in men and women with neurological disorders. Lancet. 2007;369:512-525.
66. Kadioglu P, Yalin AS, Tiryakiodlu O, et al. Sexual dysfunction in women with hyperprolactinemia: a pilot study reports. J Urol. 2005;174:1921-1925.
67. Jongpipan J, Charoenkwan K. Sexual function after radical hysterectomy for early-stage cervical cancer. J Sex Med. 2007;4:1659-1665.
68. Plotti F, Nelaj E, Sansone M, et al. Sexual function after modified radical hysterectomy for early stage cervical cancer. A prospective study. J Sex Med. 2012;9:909-917.
69. Zippe C, Nandipati K, Agarwal A, et al. Sexual dysfunction after pelvic surgery. Int J Impot Res. 2006;18:1-18.
70. Andersen BL, Cyranowski JM. Women's sexual self-schema. J Pers Soc Psychol. 1994;67:1079-1100.
71. Burri A, Spector T. Recent and lifelong sexual dysfunction in a female UK population sample: prevalence and risk factors. J Sex Med. 2011;8:2420-2430.
72. Shindel AW, Rowen TS, Lin TC, et al. An Internet survey of demographic and health factors associated with risk of sexual dysfunction in women who have sex with women. J Sex Med. 2012;9:1261-1271.
73. Oberg K, Sjogern Fugl Myer K. On Swedish women's distressing sexual dysfunctions: some concomitant conditions and life satisfaction. J Sex Med. 2005;2:169-180.
74. Chevret-Méasson M, Lavallée E, Troy S, et al. Improvement in quality of sexual life in female partners of men with erectile dysfunction treated with sildenafil citrate: findings of the index of sexual life (ISL) in a couple study. J Sex Med. 2009;6:761-769.
75. Shifren JL, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM 1 Study. Menopause. 2006;13:770-779.
76. Davis SR, Panjari M, Stanczyk FZ. Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab. 2011;96:1642-1653.
77. Van der Stege JG, Groen H, van Zadelhoff SJ, et al. Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause. 2008;15:23-31.
78. Wierman ME, Nappi RE, Avis N, et al. Endocrine aspects of women's sexual function. J Sex Med. 2010;7:561-585.
79. Pastore L, Owens A, Raymond C. Postpartum sexuality concerns among first-time parents from one U.S. academic hospital. J Sex Med. 2007;4:115-123.
80. Barrett G, Peacock J, Victor CR, et al. Cesarean section and postnatal sexual health. Birth. 2005;32:306-311.
81. Hayes R, Dennerstein L. The impact of aging on sexual function and sexual dysfunction in women: a review of population-based studies. J Sex Med. 2005;2:317-330.
82. Hayes RD, Dennerstein L, Bennet C, et al. What is the 'true' prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact? J Sex Med. 2008;5:777-787.
83. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537-544.
84. Esposito K, Maiorino MI, Bellastella G, et al. Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res. 2010;22:179-184.
85. Enzlin P, Rosen R, Wiegel M, et al. Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/EDIC study cohort. Diabetes Care. 2009;32:780-785.
86. Toorians AW, Janssen E, Laan E, et al. Chronic renal failure in sexual functioning: clinical status versus objectively assessed sexual response. Nephrol Dial Transplant. 1997;12:2654-2663.
87. Hultgren R, Sjogren B, Soderberg M, et al. Sexual function in women suffering from aortoiliac occlusive disease. Eur J Basc Endovas Surg. 1999;17:306-312.
88. Duncan LE, Lewis C, Jenkins P, et al. Does hypertension and its pharmacotherapy affect sexual function in women? Am J Hypertens. 2000;13:640-647.
89. Miller KK, Biller BM, Beauregard C, et al. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2006;91:1683-1690.
90. Verhaak CM, Smeenk JM, van Minnen A, et al. A longitudinal prospective study on emotional adjustment before, during and after consecutive fertility treatment cycles. Hum Reprod. 2005;20:2253-2260.
91. Roovers JP, van der Bom JG, Huub van der Vaart C, et al. Hysterectomy and sexual well being: prospective observational study of vaginal hysterectomy, subtotal abdominal hysterectomy, and total abdominal hysterectomy. BMJ. 2003;327:774-779.
92. Handa VL, Harvey L, Cundiff GW, et al. Sexual function among women with urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol. 2004;191:751-756.
93. Salonia A, Briganti A, Deho F, et al. Women's sexual dysfunction: a review of the "surgical landscape". Eur Urol. 2006;50:44-52.
94. Neumann DA, Houskamp BM, Pollock VE, et al. The long-term sequelae of childhood sexual abuse in women: a meta-analytic review. Child Maltreat. 1996;1:6-16.
95. Dove NL, Wiederman MW. Cognitive distraction and women's sexual functioning. J Sex Marital Ther. 2000;26:67-78.
96. Hatzichristou D, Rosen RC, Derogatis LR, et al. Recommendations for the clinical evaluation of men and women with sexual dysfunction. J Sex Med. 2010;7:337-348.
97. Leddy L, Yang C, Stuckey B, et al. Influence of PDE5 inhibitor on genital engorgement in women with female sexual arousal disorder. J Sex Med 2011;8(suppl 2):63.
98. Kuffel SW, Heiman JR. Effects of depressive symptoms and experimentally adopted schemas on sexual arousal and affect in sexually healthy women. Arch Sex Behav. 2006;35:163-177.
99. Middleton LS, Kuffel SW, Heiman JR. Effects of experimentally adopted sexual schemas on vaginal response and subjective sexual arousal: a comparison between women with sexual arousal disorder and sexually healthy women. Arch Sex Behav. 2008;37:950-961.
100. Sadovsky R, Alam W, Enecilla M, et al. Sexual problems among a specific population of minority women aged 40 to 80 years attending a primary care practice. J Sex Med. 2006;3:795-803.
101. Brotto LA, Bitzer J, Laan E, et al. Women's sexual desire and arousal disorders. J Sex Med. 2010;7:586-614.
102. Johnston JJ, Farrell S, Bouchard C, et al. The detection and management of vaginal atrophy. J Obstet Gynaecol Can. 2004;26:503-508.
103. Mainini G, Scaffa C, Rotondi M, et al. Local estrogen replacement therapy in postmenopausal atrophic vaginitis: efficacy and safety of low dose 17 beta-estradiol vaginal tablets. Clin Exp Obstet Gynecol. 2005;32:111-113.
104. Long CY, Liu CM, Hsu SC, et al. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized post menopausal women. Menopause. 2006;13:737-743.
105. Heiman JR, LoPiccolo J. Becoming orgasmic: a sexual and personal growth program for women. New York, NY: Fireside; 1988.
106. Jankovich R, Miller PR. Response of women with primary orgasmic dysfunction to audiovisual education. J Sex Marital Ther. 1978;4:16-19.
107. Brotto LA, Heiman JR, Goff B, et al. A psychoeducational intervention for sexual dysfunction in women with gynecologic cancer. Arch Sex Behav. 2008;37:317-329.
108. Candy B, Jones L, Vickerstaff V, et al. Interventions for sexual dysfunction following treatments for cancer in women. Cochrane Database Syst Rev. 2016;(2):CD005540.
109. Brotto LA, Erskine Y, Carey M, et al. A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer. Gynecol Oncol. 2012;125:320-325.
110. Trudel G, Marchand A, Ravart M, et al. The effect of a cognitive-behavioral group treatment program on hypoactive sexual desire in women. Sex Rel Ther. 2001;16:145-164.
111. Masters WH, Johnson VE. Human sexual response. Boston, MA: Little, Brown & Co; 1966.
112. Masters WH, Johnson VE. Human sexual inadequacy. Boston, MA: Little, Brown & Co; 1970.
113. Sarwer DB, Durlak JA. A field trial of the effectiveness of behavioral treatment for sexual dysfunctions. J Sex Marital Ther. 1997;23:87-97.
114. Schnarch D. Desire problems: a systemic perspective. In: Leiblum SR, Rosen RC, eds. Principles and practice of sex therapy. New York, NY: Guilford Press; 2000:17-56.
115. Verhulst J, Heiman JR. A systems perspective on sexual desire. In: Leiblum SR, Rosen RC, eds. Sexual desire disorders. New York, NY: Guilford Press; 1988:243-267.
116. Pridal CG, LoPiccolo J. Multielement treatment of desire disorders. In: Leiblum SR, Rosen RC, eds. Principles and practice of sex therapy. New York, NY: Guilford Press; 2000:57-81.
117. Fox KC, Nijeboer S, Dixon ML, et al. Is meditation associated with altered brain structure? A systematic review and meta-analysis of morphometric neuroimaging in meditation practitioners. Neurosci Biobehav Rev. 2014;43:48-73.
118. Brotto LA, Chivers ML, Millman RD, et al. Mindfulness-based sex therapy improves genital-subjective arousal concordance in women with sexual desire/arousal difficulties. Arch Sex Behav. 2016 Feb 26 [Epub ahead of print].
119. Kocsis A, Newbury-Helps J. Mindfulness in sex therapy and intimate relationships (MSIR): clinical protocol and theory development. Mindfulness. 2016;7:690-699.
120. Brotto LA, Basson R, Luria M. A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women. J Sex Med. 2008;5(7):1646-1659.
121. Carson JW, Carson KM, Gil KM, et al. Mindfulness-based relationship enhancement. Behav Ther. 2004;35:471-494.
122. Brotto LA, Basson R. Group mindfulness-based therapy significantly improves sexual desire in women. Behav Res Ther. 2014;57:43-54.
123. Mize SJS. A review of mindfulness-based sex therapy interventions for sexual desire and arousal difficulties: from research to practice. Curr Sex Health Rep. 2015;7:89-97.
124. Hucker A, McCabe MP. An online, mindfulness-based, cognitive-behavioral therapy for female sexual difficulties: impact on relationship functioning. J Sex Marital Ther. 2014;40:561-576.
125. Safarinejad MR, Hosseini SY, Asgari MA, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women. BJU Int. 2010;106:832-839.
126. Taylor MJ, Rudkin L, Bullemor-Day P, et al. Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev. 2013;(5):CD003382.
127. Segraves RT, Clayton A, Croft H, et al. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol. 2004;25:339-342.
128. Labrie F, Belanger A, Belanger P, et al. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol. 2006;99:182-188.
129. European Medicines Agency. Intrinsa (testosterone): withdrawal of the marketing authorisation in the European Union. July 2012. http://www.ema.europa.eu/ (last accessed 19 September 2016).
130. Basson R. Testosterone therapy for reduced libido in women. Ther Adv Endocrinol Metab. 2010;1:155-164.
131. Wierman ME, Arlt W, Basson R, et al. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:3489-3510.
132. Chivers ML, Rosen RC. Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms? J Sex Med. 2010;7:858-872.
133. Leddy LS, Yang CC, Stuckey BG, et al. Influence of sildenafil on genital engorgement in women with female sexual arousal disorder. J Sex Med. 2012;9:2693-2697.
134. Nurnberg HG, Hensley PL, Heiman JR, et al. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial. JAMA. 2008;300:395-404.
135. Hawton K, Catalan J, Fagg J. Low sexual desire: sex therapy results and prognostic factors. Behav Res Ther. 1991;29:217-224.
136. Krychman ML. Vaginal estrogens for the treatment of dyspareunia. J Sex Med. 2011;8:666-674.
137. Nastri CO, Lara LA, Ferriani RA, et al. Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2013;(6):CD009672.
138. Hubayter Z, Simon JA. Testosterone therapy for sexual dysfunction in postmenopausal women. Climacteric. 2008;11:181-191.
139. Basson R, Wierman ME, van Lankveld J, et al. Summary of the recommendations on sexual dysfunctions in women. J Sex Med. 2010;7:314-326.
140. LoPiccolo J, Stock WE. Treatment of sexual dysfunction. J Consult Clin Psychol. 1986;54:158-167.
141. Fichten CS, Libman E, Brender W. Methodological issues in the study of sex therapy: effective components in the treatment of secondary orgasmic dysfunction. J Sex Marital Ther. 1986;12:22-34.
142. Hurlbert DF, Apt CV. The coital alignment technique and directed masturbation: a comparative study on female orgasm. J Sex Marital Ther. 1995;21:21-29.
143. Clayton AH, Warnock JK, Kornstein SG, et al. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 2004;65:62-67.
144. Montejo AL, Deakin JF, Gaillard R, et al. Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale. J Psychopharmacol. 2015;29:1119-1128.
145. Thorp J, Simon J, Dattani D, et al. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study. J Sex Med. 2012;9:793-804.
146. Basson R, Driscoll M, Correia S. Flibanserin for low sexual desire in women: a molecule from bench to bed? EBioMedicine. 2015;2:772-773.
147. Jaspers L, Feys F, Bramer WM, et al. Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: a systematic review and meta-analysis. JAMA Intern Med. 2016;176:453-462.
148. Frühauf S, Gerger H, Schmidt HM, et al. Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis. Arch Sex Behav. 2013;42:915-933.
149. Bradford A, Meston CM. Behavior and symptom change among women treated with placebo for sexual dysfunction. J Sex Med. 2011;8:191-201.
150. Bradford A. Listening to placebo in clinical trials for female sexual dysfunction. J Sex Med. 2013;10:451-459.
151. Greenberger D, Padesky C. Mind over mood: change how you feel by changing how you think. New York, NY: Guilford Press; 1995.
152. Kabat-Zinn J. Wherever you go, there you are. New York: Hyperion; 1994.
153. Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness. New York, NY: Delta Trade Paperbacks; 1990.
154. Hanh TN. The miracle of mindfulness: a manual on meditation. Boston, MA: Beacon Press; 1976.
155. Siegel RD. The mindfulness solution: everyday practices for everyday problems. The New York: Guilford Press, 2009.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台